Market and competitive intelligence for medical device companies
Valona is a competitive and market intelligence platform for medtech strategy and intelligence teams. Continuous monitoring of competitor launches, approvals, deals and tenders helps you shape your next move instead of reacting to theirs.
Helping global medtech leaders move ahead of their markets
What can medtech strategy and intelligence teams answer with Valona?
The questions behind your next launch, deal or tender, backed by 900+ specialist medtech sources.
-
Which competitors are launching or gaining approvals in our segments?
Track 510(k), PMA and CE mark developments, launches and clinical milestones across 900+ specialist medtech sources.
-
Who is buying whom, and which portfolio gap does each deal close?
Follow medtech M&A, divestitures and partnerships, with competitor profiles that show how each deal changes a rival’s portfolio.
-
How could the EU MDR/IVDR revision change our time to market?
Monitor regulatory and notified-body developments, and use AI analysis to summarize what proposed changes could mean for your device classes.
-
Which start-ups could threaten our installed base?
Scout funding, partnerships and early clinical results in surgical robotics, PFA, AI-enabled devices and SaMD.
-
How are reimbursement decisions shifting for our device categories?
Track coverage and payment policy changes in the markets you sell into.
-
What’s changing ahead of our next tender?
Follow tender notices, procurement signals and value-based purchasing trends in the markets you sell into.
Competitive intelligence across medical device markets
Valona supports competitive and market intelligence across specialized medical device segments, from endoscopy and minimally invasive surgery to diagnostic imaging, surgical equipment, cardiovascular devices and medical robotics.
Medtech market intelligence hub
Bring clinical developments, technology shifts, reimbursement changes, and competitor activity into one structured, always up-to-date view.
Dashboards act as a central hub for market visibility, combining curated news, AI-generated analysis, and embedded content so leadership and cross-functional teams can quickly understand what is changing and why it matters.
Medical device competitor intelligence and analysis
Maintain structured competitor profiles that evolve as new intelligence flows in, tracking product news, approvals, clinical milestones, partnerships, financial performance and strategic moves across the product lifecycle.
Designed for competitive, commercial, and strategy teams, these profiles provide focused, company-level visibility that supports positioning, account planning, and executive discussions.
MedTech competitor and regulatory alerts
Receive automated alerts and curated newsletters on 510(k), PMA and CE mark approvals, EU MDR/IVDR and FDA QMSR developments, competitor moves and emerging risks.
With flexible filtering, editorial sections and AI-powered summaries, stakeholders get relevant intelligence in a clear, ready-to-use format.
4 medical device trends shaping 2027
Connected devices, product-by-product regulatory decisions, regionalizing supply chains and new business models are reshaping medtech competition. The report sets out the evidence behind each trend and 18 signals to monitor in the year ahead.
FAQ
Valona is a competitive and market intelligence platform for medtech strategy and intelligence teams. It continuously monitors 4,500+ health industry sources, including 900+ specialist medtech sources such as regulatory agencies, medical journals and clinical trial registries, within a base of 200,000+ business sources in 115 languages. Teams follow competitor launches, approvals, clinical milestones, deals, tenders and reimbursement changes, then use dashboards, competitor profiles, alerts and AI analysis to understand what each change means for their own plans.
Medical device market intelligence is the ongoing collection and analysis of information on competitors, regulation, technology, reimbursement and demand in medtech. Platforms such as Valona bring these signals into one structured view, so product, market access and strategy teams can see what is changing and test the assumptions behind launches, tenders and investments.
Medical device companies track competitor launches, regulatory approvals, clinical milestones, partnerships, acquisitions and financial results. Competitive intelligence platforms like Valona automate this, building competitor profiles that update as new intelligence arrives and sending alerts when something changes. That replaces manual source-checking and internal trackers, so teams see threats earlier and have time to prepare a response.
They monitor the FDA, EMA, notified bodies and standards organizations for submissions, approvals, guidance updates and new legislation across markets. Valona monitors these regulatory sources alongside competitor and clinical news, and its AI analysis helps teams understand what a change means for their products, submissions and market access plans. Shared alerts let regulatory and commercial teams see the same developments.
Weak signals in medtech often appear first in scientific publications, clinical study results, regulatory filings and partnership or investment news. Valona monitors these sources continuously and uses AI to surface and connect related developments, so teams can spot a technology or competitor shift while there is still time to adjust a roadmap or market plan. Valona’s 2027 medical device trends report sets out 18 signals to watch.
Valona monitors 4,500+ health industry sources, including 900+ specialist medtech and trade sources, as part of a global base of 200,000+ business sources in 115 languages. Source types include regulatory agencies, medical journals, clinical trial registries, industry associations and specialized healthcare media. Valona also tracks 1,000+ medtech and healthcare companies by name, with strongest coverage in the USA, Germany, Japan, China, Spain and Switzerland.
Endoscopy manufacturers should track competitor launches, approvals, clinical research, partnerships and acquisitions, alongside shifts such as single-use devices, AI-assisted endoscopy and advanced imaging. Valona supports endoscopy teams with monitoring across these areas and structured competitor profiles, so they can see how each shift is changing competition in their segments.
